Haseena Cassim to HIV Integrase Inhibitors
This is a "connection" page, showing publications Haseena Cassim has written about HIV Integrase Inhibitors.
Connection Strength
0,292
-
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients. Br J Clin Pharmacol. 2024 Nov; 90(11):2947-2952.
Score: 0,232
-
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Lancet HIV. 2025 Mar; 12(3):e201-e213.
Score: 0,060